Enovis (ENOV) Liabilities from Discontinued Operations (2016 - 2025)
Enovis (ENOV) reported Liabilities from Discontinued Operations of 1425000.0 for Q4 2025, down 99.78% quarter-over-quarter from 635284000.0 in Q4 2021.
Enovis (ENOV) Liabilities from Discontinued Operations (2016 - 2025) Analysis & Trends
Enovis (ENOV) has 5 years of Liabilities from Discontinued Operations data on file, last reported at 1425000.0 in Q4 2025.
- Liabilities from Discontinued Operations for Q4 2025 came in at 1425000.0, changed N/A year-over-year; the trailing twelve-month figure through Oct 2025 was 1425000.0 (changed N/A YoY), and the FY2021 annual result was 635284000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations eased to 1425000.0 in Q4 2025 per ENOV's latest filing, from 635284000.0 in the prior quarter.
- Over five years, Liabilities from Discontinued Operations peaked at 635284000.0 in Q4 2021 and troughed at 1425000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Enovis | 1.24 Bn | 1.21 Bn | 365.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 3, 2025 | 1.43 Mn |
| Oct 3, 2025 | 1.43 Mn |
| Dec 31, 2021 | 635.28 Mn |
| Dec 31, 2021 | 635.28 Mn |
| Sep 27, 2019 | 651.72 Mn |
| Sep 27, 2019 | 651.72 Mn |
| Dec 31, 2018 | 95.40 Mn |
| Dec 31, 2018 | 95.40 Mn |
| Dec 31, 2016 | 87.18 Mn |
| Dec 31, 2016 | 87.18 Mn |